Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

ClinicalTrials.gov ID: NCT00371683

Public ClinicalTrials.gov record NCT00371683. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind Active-Controlled (Enoxaparin), Parallel-Group, Multi-Center Study to Evaluate the Safety and Efficacy of Oral Apixaban in Subjects Undergoing Elective Total Knee Replacement Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn if apixaban can prevent blood clots in the leg (deep vein Thrombosis \[DVT\]) and lung (pulmonary embolism \[PE\]) that sometimes occur after knee replacement surgery and to learn how apixaban compares to enoxaparin (Lovenox®) for preventing these clots. The safety of apixaban will also be studied.

Study identification

NCT ID
NCT00371683
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
3,608 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2006
Primary completion
Apr 30, 2008
Completion
Apr 30, 2008
Last update posted
Dec 29, 2015

2006 – 2008

United States locations

U.S. sites
25
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Capstone Clinical Trials, Inc Birmingham Alabama 35205
Capstone Clinical Trials, Inc Birmingham Alabama 35209
West Alabama Research, Inc. Tuscaloosa Alabama 35406
Martin Bowen Hefley Orthopedics Little Rock Arkansas 72205
Colorado Orthopedic Consultants, Pc Aurora Colorado 80012
Colorado Joint Replacement Denver Colorado 80210
Jdpmedical Research Denver Colorado 80230
Orhtopaedic Physicians Of Colorado, P.C. Englewood Colorado 80113
Orthopedics Assocs Of Hartford Hartford Connecticut 06106
Anthony S. Unger, Md Washington D.C. District of Columbia 20006
Bay Pines Va Medical Center Bay Pines Florida 33744
Pab Clinical Research Brandon Florida 33511
Jacksonville Center For Clinical Research Jacksonville Florida 32216
Mark W. Hollmann, Md Orange City Florida 32763
Jewett Orthopaedic Clinic Winter Park Florida 32789
Atlanta Knee And Sports Medicine Decatur Georgia 30033
Americana Orthopedics Boise Idaho 83702
Intermountain Orthopaedics Boise Idaho 83702
Bluegrass Orthopaedics/Bmr Lexington Kentucky 40509
Charleston Orthopaedic Assocs. Charleston South Carolina 29414
Kelsey Seybold Clinic Houston Texas 77025
Bone & Joint Clinic Of Houston Houston Texas 77030
Gill Orthopedic Center Lubbock Texas 79410
Robert R. King, Md Lubbock Texas 79410
Unlimited Research San Antonio Texas 78217

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00371683, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 29, 2015 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00371683 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →